Use of fertility treatments needs more careful oversightBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7063.1005a (Published 19 October 1996) Cite this as: BMJ 1996;313:1005
- Stephen Jeffcoate, Consultant
- PO Box 188, Dorking, Surrey RH4 2FE
EDITOR,—The occurrence of drug induced multiple ovulation followed by multiple pregnancy represents a failure of procedures designed to protect both individuals and society from the adverse effects of medicines.1 The manufacture and quality control of the medicines themselves, in this case gonadotrophin products, have been statutorily regulated in the United Kingdom since the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial